does semaglutide affect anesthesia How Long Stay in Your System? GLP-1 Agonists Before Surgery: What

I havent looked that good in a decade

In June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight management (distinct from Rybelsus, a lower-dose oral semaglutide licensed for type 2 diabetes)

Clinical trials discovered that individuals on this drug can shed as much as 20% of their weight

The overwhelming majority of side effects are temporary, improving significantly within weeks as your body adapts to each dose level

Regulators need data in type 2 diabetes, in cardiovascular disease, and in obesity-related comorbidities like osteoarthritis and obstructive sleep apnea